Dataset opportunity
Artoptical — 医学影像数据集机会
Artoptical 持有的中等规模医学影像数据集，可用于诊断人工智能和计算机视觉。
Score
64.9
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球眼科人工智能市场 = 2024 年为 2.0923 亿美元，复合年增长率为 36.79%（2025-2030 年）（来源：Grand View Research）。[1]
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-06-16
J&J commits $1B to expand contact lens production in Florida
manufacturingdive.com ↗ - 📰press2026-06-16
J&J commits $1B to expand contact lens production in Florida
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
医学影像数据集
Modality
图像
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR 敏感（需审查个人身份信息）
Buyer persona
医疗人工智能与诊断影像公司
Artoptical 拥有一个专门的医学影像数据集，其中包含大量的角膜扫描图像和相关的`医疗记录`，包括患者处方。该数据集非常适合开发和验证高精度的诊断人工智能模型，因为它直接将眼部地形图与特定的患者数据联系起来，为眼科疾病检测算法的训练提供了全面的基础。
其商业价值根植于快速扩张的眼科人工智能市场，该市场在 2024 年估计为2.0923 亿美元，预计将以36.79% 的复合年增长率增长。[1] 由于涉及敏感健康信息（HIPAA/GDPR）、数据所有权共享以及关联的专有镜片设计参数，访问权限需协商，但这种复杂性也凸显了该数据集的稀有和高价值特性。这种独特的数据组合对于寻求在蓬勃发展的市场中建立竞争优势的买家至关重要。⚠ 尽职调查（有价值的数据，可协商访问）：包含敏感健康信息（HIPAA/GDPR），包括角膜扫描和患者处方；数据所有权可能与处方眼科医生共享；专有镜片设计参数与特定的眼部地形图相关。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
证据证实 Artoptical 拥有专有的安全图像集合，包括患者扫描和地形图，这些图像直接与光学产品订单相关联。该数据集是开发和验证诊断人工智能模型的首要资产，这对于目标是快速扩张的眼科人工智能市场的公司至关重要。随着市场预计以 36.79% 的复合年增长率增长，将影像数据与特定的处方结果联系起来的能力，为训练下一代算法提供了独特的真实依据。
See dimension details ↓- Dataset Specificity90
主导的“医疗记录”，医疗保健行业，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
买家对人工智能就绪的眼科数据的需求异常高，这得益于市场爆炸性的增长预测，复合年增长率为 36.79%。[1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
个人身份信息/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 个命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 个数据需求信号（0 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，2 个近期外部信号 — 超出已货币化数据的专有数据
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Art Optical 是一个理想的目标，因为它是一家独立的定制隐形眼镜中小制造商，其核心业务不是销售数据，但其运营过程中必然会积累关于镜片设计、适配和患者参数的有价值的专有数据。
- Deep Qualification90
✓ 通过 — Art Optical 是一个数据持有者，而不是卖家，它拥有一个连贯且高度敏感的医学影像数据集，这是其定制隐形眼镜制造的副产品；数据所有权可能与执业者混合，并且在 2025 年 3 月推出了一个新的数据接收门户。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Image collection
该公司管理一个面向医疗保健提供商的门户网站，用于上传安全图像，包括患者扫描和地形图，从而创建了一个有价值的专有存储库，用于训练计算机视觉模型。
Medical records / imaging
该数据集包括纵向的订单历史和患者陈述，提供了将影像数据与特定镜片订单和矫正结果联系起来的关键元数据。
Industrial data
该数据捕获了随时间推移的可定制镜片的详细处方参数，提供了关于基弧、直径和度数的结构化数据，这些数据可以与患者影像相关联。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Periodic (specific years not stated)
Update frequency
Periodic
Delivery
Negotiable (likely secure transfer)
Formats
Image files
License
Usage subject to negotiation, likely for AI model development and validation with strict PII controls.
Personal data
Contains PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This proprietary dataset of corneal scans linked to patient prescriptions offers high value for AI in ophthalmology diagnostic models, driven by the sector's significant growth. Its rarity and direct link between imaging and patient data justify a premium.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Artoptical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in ophthalmology market = $209.23M in 2024, CAGR 36.79% (2025-2030) (source: Grand View Research). [1]. Investment score 64.9/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Anesco — 维护日志数据集机会
View opportunity →AI 训练数据Tolid — LLM 标注语料库：加密货币新闻、生物医学专利、美妆视频
View opportunity →工业Storelectric — 工业传感器数据集机会
View opportunity →